- PAMELA JOHNSON
- CASSANDRA LYTLE STEINKE
- OLIVIA LEFEVRE
This is a one-hour didactic session where speakers deliver clinical, basic science and translational neurology and neuroscience related topics. Speakers include UW Neurology department members, including neuropsychologists, researchers, clinical faculty, neurology residents as well as other UW clinicians and researchers or invited speakers from outside UW.
Psychologists, Social Workers, Psychometrists, Neurology Residents, and Students
|Laura Hancock, PhD, Chair||Pam Johnson, Coordinator|
|Eugene Kutasevich, PsyD||Olivia Mei Zhen Lefevre, Coordinator|
|Erin Plumley, PsyD||Alanna Kessler-Jones, PsyD|
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Psychological Association (APA)
|Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.|
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are listed below.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Detailed disclosures will be available prior to the start of the activity.
Disclosures for Planning Committee
Practice-Based Learning and Improvement
DIVERSITY, EQUITY, AND INCLUSION COMPETENCIES
Engage in Self-Reflection
Address Health Disparities
Value Diversity in the Clinical Encounter
Additional Activity Goals
|JAC 14||JAC 18||JAC 20|
Non-IP — Competence
As a result of participation in this educational series, members of the healthcare team will be able to:
- Apply updated medical knowledge to evaluation of brain-behavior relationships
- Improve differential diagnosis for patients with neuropsychological disorders
- Improve the assessment and treatment of culturally diverse individuals
- Explain neurological diseases and their cognitive effects